Current Alzheimer Research

Editor-in-Chief

Prof. Debomoy K. Lahiri
(16607 citations)
Neuroscience Research Center
Indianapolis, IN 46202
(USA)

Nobel Laureates on Editorial Board

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

Back

Become EABM
Become Reviewer



Editorial: Multi Target - Directed Ligands in the Treatment of Alzheimer’s Disease free to download

Volume:16   Issue: 9
Pp: 771-771
Ondrej Soukup and Jan Korabecny
DOI: 10.2174/156720501609191029115310



Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease

Volume:16   Issue: 9
Pp: 772-800
Eva Mezeiova, Katarina Chalupova, Eugenie Nepovimova, Lukas Gorecki, Lukas Prchal, David Malinak, Kamil Kuca, Ondrej Soukup and Jan Korabecny*
DOI: 10.2174/1567205016666190228122956



Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer’s Disease

Volume:16   Issue: 9
Pp: 801-814
Damijan Knez, Izidor Sosič, Anja Pišlar, Ana Mitrović, Marko Jukič, Janko Kos and Stanislav Gobec*
DOI: 10.2174/1567205016666191010130351



Synthesis and Biological Evaluation of Novel Chromone+Donepezil Hybrids for Alzheimer’s Disease Therapy

Volume:16   Issue: 9
Pp: 815-820
Rim Malek, Bernard Refouvelet, Mohamed Benchekroun, Isabel Iriepa, Ignacio Moraleda, Rudolf Andrys, Kamil Musilek, José Marco-Contelles and Lhassane Ismaili*
DOI: 10.2174/1567205016666191011112624



Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer’s Disease

Volume:16   Issue: 9
Pp: 821-833
Martina Kaniakova, Eugenie Nepovimova, Lenka Kleteckova, Kristyna Skrenkova, Kristina Holubova, Zofia Chrienova, Vendula Hepnarova, Tomas Kucera, Tereza Kobrlova, Karel Vales, Jan Korabecny, Ondrej Soukup* and Martin Horak*
DOI: 10.2174/1567205016666190228122218



Alzheimer’s Disease: Erythrocyte 2,3-diphosphoglycerate Content and Circulating Erythropoietin

Volume:16   Issue: 9
Pp: 834-835
Petter Järemo*, Alenka Jejcic, Vesna Jelic, Tasmin Shahnaz, Homira Behbahani, Magnus Oweling and Bengt Winblad
DOI: 10.2174/1567205016666190827120108



Amyloid-β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer’s Diseases

Volume:16   Issue: 9
Pp: 836-842
Xueli Wang, See-Lok Ho, Chung-Yan Poon, Ting Yan, Hung-Wing Li* and Man Shing Wong*
DOI: 10.2174/1567205016666190827123222



HMPAO-SPECT Can Discriminate between Patients with Subjective Cognitive Complaints with and without Cognitive Deficits and those with Mild Cognitive Impairment

Volume:16   Issue: 9
Pp: 843-851
F. Rossini*, H. Zauner*, J. Bergmann, M. Kronbichler, I. Spindler, S. Golaszewski, E. Trinka and W. Staffen
DOI: 10.2174/1567205016666190827115138



Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment

Volume:16   Issue: 9
Pp: 852-860
Atsuko Eguchi, Noriyuki Kimura*, Yasuhiro Aso, Kenichi Yabuuchi, Masato Ishibashi, Daiji Hori, Yuuki Sasaki, Atsuhito Nakamichi, Souhei Uesugi, Mika Jikumaru, Kaori Sumi, Tsuyoshi Shimomura and Etsuro Matsubara
DOI: 10.2174/1567205016666190805155230



Active Amyloid-β Vaccination Results in Epigenetic Changes in the Hippocampus of an Alzheimer’s Disease-Like Mouse Model

Volume:16   Issue: 9
Pp: 861-870
Roy Lardenoije, Daniël L.A. van den Hove, Sophie E. Jung, Monique Havermans, Peter Blackburn, Bin Liu, Bart P.F. Rutten and Cynthia A. Lemere*
DOI: 10.2174/1567205016666190827122009